UY35800A - COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS - Google Patents

COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS

Info

Publication number
UY35800A
UY35800A UY35800A UY35800A UY35800A UY 35800 A UY35800 A UY 35800A UY 35800 A UY35800 A UY 35800A UY 35800 A UY35800 A UY 35800A UY 35800 A UY35800 A UY 35800A
Authority
UY
Uruguay
Prior art keywords
combinations
bruton
inhibitors
tutosina
immunoterapias
Prior art date
Application number
UY35800A
Other languages
Spanish (es)
Inventor
Levy Ronald
Chang Betty
Ng Patrick
Idit Sagiv-Barfi
Holbrook E K Kohrt
Original Assignee
Univ Leland Stanford Junior
Pharmacyclics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Pharmacyclics Inc filed Critical Univ Leland Stanford Junior
Publication of UY35800A publication Critical patent/UY35800A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Combinaciones de inhibidores de la tirosina quinasa de Bruton (BTK), por ejemplo, 1-((R)-3-(4-amino-3-(4-fenoxifenil)-1H-pirazol[3,4-d]pirimidin-1-il)piperidin-1-il)prop-2-en-1-ona, con inmunoterapias. También se proveen métodos de tratamiento de cánceres y trastornos autoinmunes que comprenden administrar combinaciones de inhibidores de tirosina quinasa de Bruton (BTK), por ejemplo, 1-((R)-3-(4-amino-3-(4-fenoxifenil)-1H-pirazol[3,4-d]pirimidin-1-il)piperidin-1-il)prop-2-en-1-ona, y un inhibidor de un punto de control inmunológico.Bruton tyrosine kinase (BTK) inhibitor combinations, for example, 1 - ((R) -3- (4-amino-3- (4-phenoxyphenyl) -1H-pyrazole [3,4-d] pyrimidin- 1-yl) piperidin-1-yl) prop-2-en-1-one, with immunotherapies. Methods of treating cancers and autoimmune disorders are also provided which comprise administering combinations of Bruton tyrosine kinase inhibitors (BTK), for example, 1- ((R) -3- (4-amino-3- (4-phenoxyphenyl)) -1 H -pyrazol [3,4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en-1-one, and an inhibitor of an immune control point.

UY35800A 2013-10-25 2014-10-28 COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS UY35800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361895988P 2013-10-25 2013-10-25
US201462023742P 2014-07-11 2014-07-11
US201462023705P 2014-07-11 2014-07-11

Publications (1)

Publication Number Publication Date
UY35800A true UY35800A (en) 2014-12-31

Family

ID=52479013

Family Applications (1)

Application Number Title Priority Date Filing Date
UY35800A UY35800A (en) 2013-10-25 2014-10-28 COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS

Country Status (1)

Country Link
UY (1) UY35800A (en)

Similar Documents

Publication Publication Date Title
BR112015021995A2 (en) combinations of bruton tyrosine kinase inhibitors and cyp3a4 inhibitors
EA201690746A1 (en) TREATMENT WITH THE USE OF BLUTON AND IMMUNOTHERAPY THYROZINKINASE INHIBITORS
ZA201903932B (en) Imidazopyrazine inhibitors of bruton's tyrosine kinase
MX2019008815A (en) Synthesis of a bruton's tyrosine kinase inhibitor.
MX2020014245A (en) Inhibitors of cyclin-dependent kinases.
MX2019001125A (en) Macrocycle kinase inhibitors.
IL256150B (en) Combining anti-hla-dr or anti-trop-2 antibodies with microtubule inhibitors, parp inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
EP3414234A4 (en) Bruton's tyrosine kinase inhibitors
MA43162A (en) BRUTON TYROSINE KINASE IMIDAZOPYRAZINE INHIBITORS
MD3265084T2 (en) Pharmaceutical formulations of Bruton's tyrosine kinase inhibtor
EP3310776A4 (en) Inhibitors of bruton's tyrosine kinase
EP3405192A4 (en) Bruton's tyrosine kinase inhibitors
EA201591656A1 (en) COMBINED THERAPY WITH IBRUTINIB
NZ745927A (en) Compounds and methods for modulating bruton’s tyrosine kinase
EP3220912A4 (en) Tlr inhibitor and bruton's tyrosine kinase inhibitor combinations
ZA201906887B (en) Bruton's tyrosine kinase inhibitors
ZA201903694B (en) Inhibitors of bruton's tyrosine kinase
DK3609886T3 (en) BENZOAZEPINE ANALOGUES AS BRUTON TYROSINE KINASE INHIBITORS
MX2017013875A (en) Certain protein kinase inhibitor.
MA52629A (en) BRUTON TYROSINE KINASE INHIBITORS
EP3452477C0 (en) Adenine derivatives as protein kinase inhibitors
ZA201808238B (en) Certain protein kinase inhibitors
EP3555092A4 (en) Protein kinase inhibitors
EA201791450A1 (en) 3,5-DIAMINOPYRAZOLES KINASE INHIBITORS
UY35800A (en) COMBINATIONS OF INHIBITORS OF THE TUTOSINA QUINASA DE BRUTON AND IMMUNOTERAPIAS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211215